Immunohistochemical localization of tenascin, estrogen receptor and transforming growth factory-β1 in human endometrial carcinoma

Gynecologic and Obstetric Investigation

Volumn 41, Issue 1, 1996, Pages 61-66

  Doi, Daisuke ^a   Araki, Tsutomu ^a   Asano, Goro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Endometrial carcinoma; Estrogen receptor; Tenascin; Transforming growth factor 1

Indexed keywords

ESTROGEN RECEPTOR; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; EXTRACELLULAR SPACE; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; EXTRACELLULAR SPACE; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICROSCOPY, IMMUNOELECTRON; RECEPTORS, ESTROGEN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030034909     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000292041     Document Type: Article

References (18)

1. Chiquet M, Fambrough DM: Chick myotendi-nous antigen. I. A monoclonal antibody as a marker for tendon and muscles morphogenesis. J Cell Biol 1984;98:1926-1936.
2. Oike Y, Hiraiwa G, Kawakatsu H, Nishikai M, Okinaka T, Suzuki T, Okada A, Yatani R, Sakakura T: Isolation and characterization of human fibroblast tenascin. An extracellular matrix glycoprotein of interest for developmental studies. Int J Dev Biol 1990;34:309-317.
3. Sakakura T: Cell-cell interaction in pathology. Analysis of molecular mechanism (in Japanese). Trans Soc Pathol Jpn 1992;81:51-75.
4. Shoji T, Kamiya T, Tsubura A, Hamada Y, Hatano T, Hioki K, Morii S: Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J Surg Res 1993;55: 295-297.
5. Sugawara I, Hirakoshi J, Masunaga A, Itoyama S, Sakakura T: Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis. Invasion Metastasis 1991;11:325-331.
6. Anbahagan R, Sakakura T, Gusterson BA: The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of ber., ign and malignant squamous epithelia. Virchows Arch B Cell Pathol 1990;59:59-63.
7. Sasano H, Nagura H, Watanabe K, Ito K, Tsui-ki K, Sato S, Yajima A, Kusakabe M, Sakakura T: Tenascin expression in normal and abnormal human endometrium. Mod Pathol 1993;6: 323-326.
8. Pearson CA, Pearson D, Shibahara S, Hof-steenge J, Chiquet-Ehrismann R: Tenascin: cDNA cloning and induction by TGF-ß. EMBOJ 1988;7:2977-2982.
9. Chiquet-Ehrismann R, Kalla P, Pearson CA: Participation of tenascin and transforming growth factor ß in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res 1989;49:4322-4325.
10. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohisto-chcmical staining based on microwave oven heating of tissue sections. J Histochem Cyto-chem 1991;39:741-748.
11. Gulcher JR, Nies DE, Marton LS, Stefnsson K: An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sei USA 1989;86:1588-1592.
12. Moscatelli D. Rifkin DB: Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 1988;948:67-85.
13. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
14. Ferguson JE, Schor AM, Howell A, Ferguson MWJ: Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation 1990; 42:199-207.
15. Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the resting human breast. Br J Cancer 1981;44:177-181.
16. Key TJA, Pike MC: The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-212.
17. Murray K, Haussier CA, Trookman NS: Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res 1987; 47:4909-4914.
18. Moses HL, Yang EY, Pietenpol JA: TGF-ß stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990;63:245-247.